Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37.

[1]  K. Nagata,et al.  Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts. , 2007, Life sciences.

[2]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[3]  C. Hogaboam,et al.  Infectious disease, the innate immune response, and fibrosis. , 2007, The Journal of clinical investigation.

[4]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[5]  Y. Tada,et al.  Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism , 2006, Modern rheumatology.

[6]  M. Raghunath,et al.  Defensins HNP1 and HBD2 stimulation of wound-associated responses in human conjunctival fibroblasts. , 2006, Investigative ophthalmology & visual science.

[7]  H. Kawachi,et al.  Transcription factor Ets-1 is essential for mesangial matrix remodeling. , 2006, Kidney international.

[8]  T. Luger,et al.  Melanocortins in fibroblast biology – current update and future perspective for dermatology , 2004, Experimental dermatology.

[9]  H. Hammes,et al.  Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Raghunath,et al.  Collagen Metabolism Is a Novel Target of the Neuropeptide α-Melanocyte-stimulating Hormone* , 2004, Journal of Biological Chemistry.

[11]  M. Raghunath,et al.  Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. , 2004, The Journal of biological chemistry.

[12]  P. Elsbach.  What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? , 2003, The Journal of clinical investigation.

[13]  S. Zahler,et al.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. , 2003, The Journal of clinical investigation.

[14]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[15]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[16]  V. Sementchenko,et al.  Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-β* , 2002, The Journal of Biological Chemistry.

[17]  H. Akiyama,et al.  Effects of human neutrophil peptide-1 on the expression of interstitial collagenase and type I collagen in human dermal fibroblasts , 2002, Archives of Dermatological Research.

[18]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[19]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[20]  K A Arndt,et al.  Keloids and hypertrophic scars: review and treatment strategies. , 1999, Seminars in cutaneous medicine and surgery.

[21]  Domenico Romeo,et al.  Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain , 1995, FEBS letters.

[22]  M. Klagsbrun,et al.  Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. , 1994, Proceedings of the National Academy of Sciences of the United States of America.